Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
The statement touches on issues such as the reporting of secondary findings, adult-onset conditions, incest, and non-paternity results.
ImmunArray is launching the SLE-Key Rule Out test to exclude a diagnosis of lupus, a test run on its multiple-antigen microarray-based technology.
Using genome sequencing data on 30 Brazilians and genotyping information on almost 6,500 more, the Brazilian EPIGEN Project Consortium considered ancestry and admixture patterns in three parts of Brazil.
The microarray facilitates drug screening in cancer stem cells and other rare cell populations.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.